BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27095478)

  • 21. The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
    Moyal L; Feldbaum N; Goldfeiz N; Rephaeli A; Nudelman A; Weitman M; Tarasenko N; Gorovitz B; Maron L; Yehezkel S; Amitay-Laish I; Lubin I; Hodak E
    PLoS One; 2016; 11(1):e0146115. PubMed ID: 26752418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP depletion induced cochlear hair cells death through histone deacetylation in vitro.
    Fan B; Wang J; Zha D; Qiu J; Chen F
    Neurosci Lett; 2020 May; 727():134918. PubMed ID: 32200029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
    Richon VM
    Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with the Ferroptosis Inhibitor Ferrostatin-1 Attenuates Noise-Induced Hearing Loss by Suppressing Ferroptosis and Apoptosis.
    Ma PW; Wang WL; Chen JW; Yuan H; Lu PH; Gao W; Ding XR; Lun YQ; Liang R; He ZH; Yang Q; Lu LJ
    Oxid Med Cell Longev; 2022; 2022():3373828. PubMed ID: 36531206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal.
    Chen WY; Zhang H; Gatta E; Glover EJ; Pandey SC; Lasek AW
    Alcohol; 2019 Aug; 78():79-87. PubMed ID: 30851364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine attenuates noise-induced permanent hearing loss in diabetic rats.
    Wu HP; Hsu CJ; Cheng TJ; Guo YL
    Hear Res; 2010 Aug; 267(1-2):71-7. PubMed ID: 20430080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
    Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
    J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.
    Kim DW; Park JW; Willingham MC; Cheng SY
    Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
    Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
    Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled hydrogen gas therapy for prevention of noise-induced hearing loss through reducing reactive oxygen species.
    Kurioka T; Matsunobu T; Satoh Y; Niwa K; Shiotani A
    Neurosci Res; 2014 Dec; 89():69-74. PubMed ID: 25196919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.
    Faraco G; Pancani T; Formentini L; Mascagni P; Fossati G; Leoni F; Moroni F; Chiarugi A
    Mol Pharmacol; 2006 Dec; 70(6):1876-84. PubMed ID: 16946032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.
    Saha B; Parks RJ
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity.
    Ranganathan P; Hamad R; Mohamed R; Jayakumar C; Muthusamy T; Ramesh G
    Kidney Int; 2016 Feb; 89(2):317-26. PubMed ID: 26509586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells.
    Fetoni AR; Rolesi R; Paciello F; Eramo SLM; Grassi C; Troiani D; Paludetti G
    Free Radic Biol Med; 2016 Dec; 101():211-225. PubMed ID: 27769922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
    Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
    Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells.
    Dudakovic A; Camilleri ET; Lewallen EA; McGee-Lawrence ME; Riester SM; Kakar S; Montecino M; Stein GS; Ryoo HM; Dietz AB; Westendorf JJ; van Wijnen AJ
    J Cell Physiol; 2015 Jan; 230(1):52-62. PubMed ID: 24912092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suberoylanilide Hydroxamic Acid Restores Estrogen Reduced-cTnI Expression in Neonatal Hearts of Mice.
    Peng C; Luo X; Xing Q; Sun H; Huang X
    J Cell Biochem; 2016 Oct; 117(10):2377-84. PubMed ID: 27379430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage.
    Conti C; Leo E; Eichler GS; Sordet O; Martin MM; Fan A; Aladjem MI; Pommier Y
    Cancer Res; 2010 Jun; 70(11):4470-80. PubMed ID: 20460513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
    Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
    Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.